The groundbreaking decision is a win for harm reduction, though it also highlights absurd contradictions in the FDA's overall ...

Cigarette giant Philip Morris International on Thursday forecast better-than-expected profit growth for 2025, with ...

The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to ...

Altria Group stock dipped in Thursday morning trading after the maker of Marlboro cigarettes reported fourth-quarter and full-year earnings that matched analysts’ estimates. Shares of Altria Group ...

We recently published a list of 10 Best Sin Stocks to Invest in 2025. In this article, we are going to take a look at where Philip Morris International Inc. (NYSE:PM) stands against other best sin ...

which are considered one product since they all share the same active ingredient, semaglutide. Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy ...

Federal health officials have authorized the marketing and sale of Zyn nicotine pouches, marking the first time the Food and Drug Administration authorized these popular products that go between a ...

The agency highlighted that Zyn contains fewer harmful ingredients compared to traditional tobacco products, making it less risky while helping adult smokers transition away from cigarettes.

There is no evidence that the active ingredient in Bovaer, an emissions-reducing additive fed to cows, is present in dairy products that are eventually consumed by humans, contrary to suggestion ...

FDA officials said Thursday that Zyn contains fewer harmful ingredients than cigarettes and various types of chewing tobacco, including snuff, which are linked to cancer and other life-threatening ...